Biostage, Inc.

BSTG · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$2,486$1,241$1,242
Short-Term Investments$0$0$0
Receivables$231$0$0
Inventory$80$0$0
Other Curr. Assets$437$353$12
Total Curr. Assets$3,234$1,594$1,292
Property Plant & Equip (Net)$304$196$279
Goodwill$0$0$0
Intangibles$0$0$0
Long-Term Investments$0$0$0
Tax Assets$0$0$0
Other NC Assets$904$610$295
Total NC Assets$1,208$806$574
Other Assets$0$0$0
Total Assets$4,442$2,400$1,866
Liabilities
Payables$452$682$676
Short-Term Debt$95$99$110
Tax Payable$0$0$0
Deferred Revenue$0$0$2,462
Other Curr. Liab.$474$582$1,588
Total Curr. Liab.$1,021$1,363$3,250
LT Debt$199$48$59
Deferred Rev, NC$0$0$0
Deferred Tax Liab, NC$0$0$0
Other NC Liab.$0$0$1,586
Total NC Liab.$199$48$1,645
Other Liabilities$0$0$0
Cap. Leases$0$0$0
Total Liabilities$1,220$1,411$4,895
Equity
Pref Stock$0$4,180$0
Common Stock$159$122$108
Retained Earnings-$99,688-$83,011-$76,938
AOCI-$6$0$0
Other Equity$102,757$79,698$73,801
Total Equity$3,222$989-$3,029
Supplemental Information
Minority Interest$0$0$0
Total Liab. & Tot. Equity$4,442$2,400$1,866
Net Debt-$2,192$0-$1,094-$1,073